Open AccessCombined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors
Author(s) -
Silvia Nicolini,
Lisa Bodei,
Alberto Bongiovanni,
Maddalena Sansovini,
Ilaria Grassi,
Toni Ibrahim,
Manuela Monti,
Paola Caroli,
Anna Sarnelli,
Danila Diano,
Valentina Di Iorio,
Chiara Maria Grana,
Corrado Cittanti,
Federica Pieri,
Stefano Severi,
Giovanni Paganelli
Publication year - 2021
Publication title -
european journal of nuclear medicine and molecular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.313
H-Index - 163
eISSN - 1619-7089
pISSN - 1619-7070
DOI - 10.1007/s00259-021-05236-z
Subject(s) - capecitabine , medicine , neuroendocrine tumors , gastro , neuroendocrine tumour , nuclear medicine , oncology , gastroenterology , cancer , colorectal cancer , disease , reflux
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom